Please be aware of scams that can affect investors.
The value of investments and the income from them may go down as well as up and investors may get back less than the amount invested. The tax benefits relating to ISA investments may not be maintained. Please refer to the Key Facts documents contained in the ISA/Share Plan Brochure & Application form for general and specific investment risks attaching to the individual trusts.Read the detailed Risk Warning
Past performance is not a guide to future results.
See latest monthly factsheet below for performance history.
At close 18-Jun-2013Ord
|Net Dividend Yield||3.65%|
|Net Dividend Yield||3.13%|
* Debt at market value
** Debt at par
Source: Morningstar, NAV = Net Asset Value, excluding income.
40 Princes Street,
Registered in Scotland as an Investment Company Number SC0006705
The objective of Murray International Trust PLC is to achieve a total return greater than its benchmark by investing predominantly in equities worldwide. Within this objective the Manager will seek to increase the Company’s revenues in order to maintain an above average dividend yield.
Bruce Stout, acclaimed manager of Murray International Trust, talks to Money Observer editor Andrew Pitts about a potential dividend bubble in Asia and how he sees 2013 shaping up for investors
In this webcast, Bruce Stout gives an update on a wide range of subjects including performance, sector and geographic breakdowns, and the twenty largest investments in the Trust.
The global economic backdrop drifted aimlessly over the period. In the absence of any definitive change in prevailing economic activity, growth remained scarce, inflation relatively stable and unemployment stubbornly high. Business and consumer sentiment remained fragile, weighed down by widespread uncertainty towards future growth and income prospects.
Global equity market performance over the month matched the moribund mood of macroeconomics. Pockets of strength in Europe and Japan were offset by notable weakness in China and Latin America. The US and UK made no progress in sterling terms, leaving global aggregate market returns essentially flat.
The large position in Kimberly-Clark de Mexico was reduced by 1% following a prolonged period of strong capital appreciation. Profits were also realised through partial sales of two pharmaceutical companies, Astellas in Japan and Novartis in Switzerland.
The complete lack of economic traction in response to persistent money printing is a macroeconomic reality that appears not to register in the minds of Global Central Bankers intent on debasing their respective currencies. So quantitative easing prevails and the world continues to stagnate. Whilst such policy irresponsibility dictates, capital preservation remains key. The portfolio’s predominately defensive positioning will be maintained.
Source: Monthly Factsheet Aberdeen Asset Managers Limited